natgillin/translations-raw huggingface dataset:
They may be extremely tired, and have dark urine, pale faces, yellowish skin and/or eyes (jaundice), and other signs of the disease possibly requiring hospitalisation. 
Ti ljudje so lahko zelo utrujeni, imajo temen urin, svetlo blato, rumenkasto kožo in/ali oči (zlatenica) in druge bolezenske znake zaradi katerih je lahko potreben sprejem v bolnišnico.
not less than 30 International Units 
ne manj kot 30 mednarodnih enot
Do not be alarmed by this list of possible side effects. 
Naj vas ta seznam neželenih učinkov ne prestraši.
not less than 4 International Units 
ne manj kot 4 mednarodne enote
Do not use after the expiry date stated on the pack. 
Cepiva ne uporabljajte po datumu izteka roka uporabnosti, ki je naveden na ovojnini.
Your child will receive a total of three injections with an interval of at least one month between each one. 
Vaš otrok bo prejel skupaj tri odmerke z vsaj enomesečnim vmesnim presledkom.
WHAT QUINTANRIX IS AND WHAT IT IS USED FOR 
KAJ JE CEPIVO QUINTANRIX IN ZA KAJ GA UPORABLJAMO
No preclinical safety testing with the vaccine has been conducted. 
Predklinične študije o varnosti cepiva niso bile izvedene.
The primary vaccination schedule consists of three doses of 0.5 ml to be administered at intervals of at least 4 weeks within the first six months of life in accordance with local official recommendations. 
Shema osnovnega cepljenja je sestavljena iz treh odmerkov po 0,5 ml, ki se jih v skladu z uradnimi lokalnimi priporočili daje v prvih šestih mesecih življenja.
Side effects that occurred during clinical trials with Quintanrix were as follows: 
Neželeni učinki, ki so se pojavili med kliničnimi študijami s cepivom Quintanrix so bili naslednji:
• if after previously having Quintanrix or another vaccine against pertussis (whooping cough) disease, your child had any problems, especially: ♦ A high temperature (over 40°C) within 48 hours of vaccination ♦ A collapse (floppiness) or shock-like state within 48 hours of vaccination ♦ Persistent crying lasting 3 hours or more within 48 hours of vaccination ♦ Seizures/fits with or without a high temperature within 3 days of vaccination 
• če je imel vaš otrok kakršne koli težave po predhodnem cepljenju s cepivom Quintanrix ali drugim cepivom proti oslovskemu kašlju, še posebej: ♦ visoko telesno temperaturo (nad 40 ºC) v 48 urah po cepljenju, ♦ kolaps (ohlapnost) ali šoku podobno stanje v 48 urah po cepljenju, ♦ če je v 48 urah po cepljenju vztrajno in neutolažljivo jokal 3 ure ali dlje, ♦ epileptične napade/krče z ali brez zvišane telesne temperature v 3 dneh po cepljenju,
The DTPw-HBV component should be well shaken in order to obtain a homogeneous turbid white suspension and should be inspected visually for any foreign particulate matter and/or abnormal physical appearance. 
Komponento DTPw-HBV je potrebno dobro pretresti, da nastane homogena motna bela suspenzija, potrebno pa jo je tudi vizualno preveriti glede morebitne prisotnosti tujih delcev in/ali neobičajnega fizikalnega izgleda.
not less than 60 International Units 
ne manj kot 60 mednarodnih enot
GlaxoSmithKline Biologicals S.A. 2100 Gödöllö, Táncsics Mihály út 82 Hungary 
GlaxoSmithKline Biologicals S.A. 2100 Gödöllö, Táncsics Mihály út 82 Madžarska
• Diphtheria: Diphtheria mainly affects the airways and sometimes the skin. 
• Davica: Davica v glavnem prizadene dihalne poti in včasih tudi kožo.
The seroprotection rates for anti-HBs (≥10 mlU/ml) observed with the 6, 10, 14 week schedule was lower as shown in the table below, but is unlikely to be clinically relevant due to the small sample size: 
Odstotek serozaščite s proti-HBs ((≥ 10 i.e./ml) opažen pri shemi 6., 10., 14. teden je bil nižji od navedenega v preglednici v nadaljevanju, vendar pa je zaradi majhne velikosti vzorca malo verjetno, da bi to imelo klinični pomen:
There may be circumstances, such as a high incidence of pertussis, when the potential benefits outweigh possible risks. 
V nekaterih okoliščinah, npr. v primeru visoke incidence oslovskega kašlja, lahko pričakovana korist cepljenja prevlada nad možnim tveganjem.
The active substances and other ingredients in Quintanrix are listed at the beginning of the leaflet. 
Učinkovine in druge sestavine v cepivu Quintanrix so navedene na začetku navodila.
GlaxoSmithKline Biologicals S.A. 89 rue de I'Institut-1330 Rixensart Belgium 
GlaxoSmithKline Biologicals S.A. 89 rue de I'Institut-1330 Rixensart Belgija
Wounds that are especially prone to infection are burns, fractures, deep wounds or wounds contaminated with soil, dust, horse manure/dung or wood splinters. 
Rane, ki so še posebej nagnjene k okužbi so opekline, zlomi, globoke rane ali rane onesnažene z zemljo, s prahom, konjskim gnojilom/z iztrebki ali lesenimi trskami.
SPECIAL STORAGE CONDITIONS Store in a refrigerator Do not freeze 
POSEBNA NAVODILA ZA SHRANJEVANJE Shranjujte v hladilniku.
When using a multidose vial, each 0.5 ml dose of the reconstituted suspension should be taken with a sterile needle and syringe. 
Pri uporabi večodmerne viale je potrebno vsak odmerek po 0,5 ml odvzeti s sterilno iglo in brizgo.
Tetanus toxoid1 
Tetanusni toksoid1
BEFORE YOUR CHILD RECEIVES QUINTANRIX 
PREDEN VAŠ OTROK DOBI CEPIVO QUINTANRIX
These may be local or widespread rashes that may be itchy or blistering, swelling of the eyes and face, difficulty in breathing or swallowing, a sudden drop in blood pressure and loss of consciousness. 
Te se lahko pojavijo v obliki omejenih ali razširjenih, srbečih ali mehurčastih izpuščajev, otekline oči in obraza, težav pri dihanju ali požiranju, nenadnega padca krvnega tlaka ali izgube zavesti.
• Tetanus (Lockjaw): Tetanus bacteria enter the body through cuts, scratches or wounds in the skin. 
• Tetanus (mrtvični krč): Bakterije, povzročiteljice tetanusa vdrejo v telo skozi vreznine, opraskanine ali rane na koži.
What Quintanrix is and what it is used for Before your child receives Quintanrix How Quintanrix is given Possible side effects 
Kaj je cepivo Quintanrix in za kaj ga uporabljamo Preden vaš otrok dobi cepivo Quintanrix Kako se cepivo Quintanrix daje Možni neželeni učinki
Important information about some of the ingredients of Quintanrix 
Pomembne informacije o nekaterih sestavinah cepiva Quintanrix
HIV infection is not considered as a contraindication. 
Okužba z virusom humane imunske pomanjkljivosti (HIV) ne velja za kontraindikacijo.
After the addition of the DTPw-HBV component to the HIB powder, the mixture should be well shaken until the powder is completely dissolved. 
Po dodajanju komponente DTPw-HBV komponenti HIB v obliki praška, je potrebno mešanico dobro pretresti, da se prašek popolnoma raztopi.
• Convulsions with or without fever, occurring within 3 days. 
• Krči z zvišano telesno temperaturo ali brez nje, ki so se pojavili v 3 dneh.
♦ Very common (more than 1 per 10 doses of vaccine): 
♦ Zelo pogosti (več kot 1 na 10 odmerkov cepiva):
Vaccination should be preceded by a review of the medical history (especially with regard to previous vaccination and possible occurrence of undesirable events). 
Pred cepljenjem je potrebno oceniti anamnezo (s poudarkom na predhodnih cepljenjih in morebitnih neželenih učinkih).
- The other ingredients in the vaccine are: lactose, thiomersal (preservative), sodium chloride and water for injections. 
- Druge sestavine cepiva so: laktoza, tiomersal (konzervans), natrijev klorid in voda za injiciranje.
Seroprotection and vaccine response rates were similar for the three schedules used, with the exception of anti-HBs. 
Serozaščita in odstotek odziva na cepivo je bil pri vseh treh uporabljenih shemah podoben, izjema so bila le protitelesa proti-HBs.
• if your child has previously had any allergic reaction to Quintanrix, or any ingredient contained in this vaccine. 
• če je imel vaš otrok predhodno kakršno koli alergijsko (preobčutljivostno) reakcijo na cepivo Quintanrix ali na katero koli sestavino v tem cepivu.
This medicinal product contains thiomersal (an organomercuric compound) as a preservative and therefore it is possible that sensitisation reactions may occur (see section 4.3). 
To cepivo vsebuje kot konzervans tiomersal (organska živosrebrova spojina) in tako je možen pojav preobčutljivostnih reakcij (glejte poglavje 4.3).
This is a multidose container. 
Vsebnik vsebuje več odmerkov.
• if your child has any known allergies. 
• če ima vaš otrok katero koli znano alergijo (preobčutljivost).
The immune response after a three-dose primary vaccination course was evaluated in five trials: 297 infants were evaluated after vaccination at 6, 10 and 14 weeks of age, 685 after vaccination at 2, 4, and 6 months of age and 107 after vaccination at 3, 4 and 5 months of age. 
Imunski odziv po osnovnem cepljenju s tremi odmerki cepiva je bil ovrednoten s petimi raziskavami: pri 297 otrocih, ki so bili cepljeni po shemi 6., 10. in 14 teden starosti, pri 685 otrocih, ki so bili cepljeni po shemi 2., 4. in 6. mesec starosti in pri 107 otrocih, ki so bili cepljeni po shemi 3., 4. in 5. mesec starosti.
Vaccinees with a history of febrile convulsions should be closely followed up as such adverse events may occur within 2 to 3 days post vaccination. 
Otroke, ki jih cepimo in imajo vročinske krče v anamnezi, je potrebno skrbno nadzirati, saj se takšni neželeni dogodki lahko pojavijo v 2 do 3 dneh po cepljenju.
There will be some type of serious complications such as: mental retardation, cerebral palsy, deafness, epilepsy or partial blindness. 
Okužba lahko povzroči nekatere resne komplikacije kot so: mentalna zaostalost, paraliza možganov, gluhota, epilepsija in delna oslepelost.
Quintanrix was administered as a booster to 435 infants in the second year of life. 
Obnovitveni odmerek cepiva Quintanrix je v drugem letu življenja prejelo 435 otrok.
2adsorbed on aluminium phosphate 
2adsorbiran na aluminijev fosfat
• if your child experienced problems of the nervous system (such as repetitive fits, decrease of consciousness) within 7 days after previous vaccination with a vaccine against pertussis (whooping cough) disease. 
• če je imel vaš otrok težave z živčevjem (npr. ponavljajoči se krči, zmanjšana stopnja zavesti) v prvih 7 dneh po cepljenju s cepivom proti oslovskemu kašlju;
• Fever (more than 37.5°C) 
• zvišana telesna temperatura (večja od 37,5 ºC)
4.5 Interaction with other medicinal products and other forms of interaction In paediatric vaccination it is often practice to co-administer different injectable vaccines at separate injection sites, during the same session. 
4.5 Medsebojno delovanje z drugimi zdravili in druge oblike interakcij Pogosta praksa pri cepljenju otrok je, da se jih ob enkratnem obisku cepi z različnimi cepivi za injiciranje, ki se jih injicira na ločenih mestih.
• Pain, redness or swelling at the injection site 
• bolečina, rdečina in oteklina na mestu injiciranja
If these events continue or become severe, tell your doctor. 
Če ti neželeni učinki ne minejo ali postanejo hujši, obvestite svojega zdravnika.
Nervous system disorders: very common: drowsiness rare: collapse or shock-like state (hypotonic-hyporesponsiveness episode), convulsions 
Bolezni živčevja: zelo pogosti: zaspanost redki: kolaps ali šoku podobno stanje (hipotonična-hiporesponzivna epizoda), konvulzije
Store in the original package in order to protect from light. 
Za zagotovitev zaščite pred svetlobo shranjujte v originalni ovojnini.
6.6 Instructions for use and handling 
6.6 Navodila za pripravo in ravnanje z zdravilom
A fine needle can be used for the vaccination and firm pressure applied to the site (without rubbing) for at least two minutes following administration. 
Pri cepljenju je potrebno uporabiti tanko iglo in nato na mesto aplikacije trdno pritiskati (brez drgnjenja) najmanj dve minuti.
Less commonly, the bacteria can also infect the blood, heart, lungs, bones, joints, and tissues of the eyes and mouth. 
Bakterije lahko, vendar manj pogosto, okužijo tudi kri, srce, pljuča, kosti, sklepe in tkiva oči ter ust.
Quintanrix can be given to children who have received hepatitis B vaccine at birth. 
S cepivom Quintanrix se lahko cepi otroke, ki so ob rojstvu prejeli cepivo proti hepatitisu B.
The booster dose should preferably be given at least 6 months after the last primary dose. 
Otrok mora obnovitveni odmerek po možnosti prejeti vsaj 6 mesecev po zadnjem odmerku osnovnega cepljenja.
Thiomersal Sodium chloride Water for injections 
laktoza tiomersal natrijev klorid voda za injiciranje
• Fever (more than 39°C) 
• zvišana telesna temperatura (večja od 39 ºC)
The vaccine is reconstituted by withdrawing the contents of the vial containing the DTPw-HBV component by means of a syringe and by adding it to the vial containing the HIB powder. 
Cepivo se rekonstituira tako, da se vsebina viale s komponento DTPw-HBV odvzame z brizgo in se doda viali s komponento HIB v obliki praška.
Not all pack sizes may be marketed. 
Možno je, da na tržišču ni vseh navedenih pakiranj.
Haemophilus influenzae type b polysaccharide (polyribosylribitol phosphate) 2 
Polisaharid bakterije Haemophilus influenzae tipa b (poliribozilribitol-fosfat)2
6, 10, 14 weeks schedule N = 97 
Shema 6., 10., 14. teden N = 97
♦ Rare (less than 1 per 1000 but more than 1 per 10 000 doses of vaccine): 
♦ Redki (manj kot 1 na 1.000 vendar več kot 1 na 10.000 odmerkov cepiva):
Hypersensitivity to the active substances or to any of the excipients. 
Preobčutljivost za aktivne sestavine ali katero koli pomožno snov cepiva.
As shown with other vaccines, the booster dose is potentially associated with an increased incidence of minor adverse events such as fever and local reactions. 
Obnovitveni odmerek je, tako kot pri drugih cepivih, povezan s povečano pojavnostjo blažjih neželenih dogodkov, kot so povišana telesna temperatura in lokalne reakcije.
The following schedules have been studied in clinical trials: 2-4-6 months, 3-4-5 months and 6-10-14 weeks. 
Med kliničnim preskušanjem so bile opravljene študije z naslednjimi shemami: 2., 4., 6. mesec; 3., 4., 5. mesec in 6., 10., 14. teden.
It is possible that your child will have no side effects from vaccination. 
Možno je, da vaš otrok po cepljenju ne bo imel nikakršnih neželenih učinkov.
As with all injectable vaccines, there is an extremely small risk of allergic reactions. 
Tako kot pri vseh cepivih za injiciranje, tudi pri tem obstaja izjemno majhno tveganje za pojav alergijskih (preobčutljivostnih) reakcij.
The vaccine will not prevent infection caused by other pathogens known to infect the liver such as hepatitis A, hepatitis C and hepatitis E virus. 
Cepivo ne bo preprečilo okužb z drugimi patogeni, ki lahko prizadenejo jetra, npr. okužbe z virusom hepatitisa A, virusom hepatitisa C in virusom hepatitisa E.
Hepatitis B carriers are at risk of serious liver disease, such as cirrhosis (liver scarring) and liver cancer. 
Pri klicenoscih virusa hepatitisa B obstaja tveganje za resne bolezni jeter kot sta ciroza (brazgotinjenje jeter) in rak jeter.
Data from clinical trials show that Quintanrix, when given as a booster dose in the second year of life, induces a greater than 10-fold increase in mean antibody titre with respect to prebooster levels for all vaccine components. 
Vendar pa podatki iz kliničnih raziskav kažejo, da dajanje obnovitvenega odmerka cepiva Quintanrix v drugem letu življenja povzroči več kot 10-kratni porast srednjega titra protiteles proti vsem komponentam cepiva glede na vrednosti pred obnovitvenim cepljenjem.
For any information about this medicinal product, please contact the local representative of the Marketing Authorisation Holder. 
Za vse morebitne nadaljnje informacije o tem cepivu se lahko obrnete na predstavništvo imetnika dovoljenja za promet.
• Haemophilus influenzae type b (HIB): HIB infection most frequently causes brain inflammation (swelling). 
• Haemophilus influenzae tipa b (HIB): Okužba s HIB najpogosteje povzroči vnetje možganov (oteklino).
2, 4, 6 months schedule N = 672 
Shema 2., 4., 6. mesec N = 672
The presence of a minor infection, such as a cold, is not a contraindication for vaccination. 
Blage okužbe, npr. prehlad niso kontraindikacija za cepljenje.
Booster administration should be in accordance with official recommendations. 
Obnovitveno cepljenje mora biti v skladu z uradnimi priporočili.
2.5 µg conjugated to tetanus toxoid as a carrier 
2,5 µg konjugiran na tetanusni toksoid kot nosilec
A minor infection such as a cold should not be a problem, but talk to your doctor first. 
Blažje okužbe, kot na primer prehlad običajno ni ovira, vendar se pred cepljenjem vseeno pogovorite z zdravnikom;
Quintanrix is contra-indicated if the child has experienced an encephalopathy of unknown aetiology, occurring within 7 days following previous vaccination with pertussis containing vaccine. 
Uporaba cepiva Quintanrix je kontraindicirana, če je otrok prebolel encefalopatijo neznanega vzroka, ki se je pojavila v 7 dneh po predhodnem cepljenju s cepivom, ki je vsebovalo tudi komponento proti oslovskemu kašlju.
Hepatitis B surface antigen (rDNA) 2, 3 
Rekombinantni površinski antigen virusa hepatitisa B2, 3
HOW QUINTANRIX IS GIVEN 
KAKO SE CEPIVO QUINTANRIX DAJE
This medicinal product contains thiomersal as a preservative and it is possible that your child may experience an allergic reaction. 
To cepivo kot konzervans vsebuje tiomersal in zato je pri vašem otroku možen pojav alergijske reakcije.
≥ 4 IU 
≥ 4 i.e.
As with other vaccines, the administration of Quintanrix should be postponed in subjects suffering from acute severe febrile illness. 
Kot pri cepljenju z drugimi cepivi je potrebno cepljenje s cepivom Quintanrix odložiti pri osebah, ki prebolevajo hudo akutno vročinsko bolezen.
Quintanrix is for deep intramuscular injection, preferably in the anterolateral thigh. 
Cepivo Quintanrix se injicira globoko intramuskularno, najboljše v anterolateralni predel stegna.
Adverse reactions reported after booster vaccination are listed below. 
Neželene reakcije o katerih so poročali po obnovitvenem cepljenju so navedene v nadaljevanju.
Quintanrix should under no circumstances be administered intravascularly. 
Cepivo Quintanrix se v nobenem primeru ne sme dajati v žilo.
♦ Common (less than 1 per 10 but more than 1 per 100 doses of vaccine): 
♦ Pogosti (manj kot 1 na 10 vendar več kot 1 na 100 odmerkov cepiva):
2.5 micrograms conjugated to tetanus toxoid as a carrier 
2,5 mikrograma konjugiran na tetanusni toksoid kot nosilec
BEFORE YOUR CHILD RECEIVES QUINTANRIX In the following cases, Quintanrix should not be given to your child. You must tell your doctor: 
PREDEN VAŠ OTROK DOBI CEPIVO QUINTANRIX V naslednjih primerih se cepivo Quintanrix vašemu otroku ne sme dati.
A history of febrile convulsions, a family history of convulsions or Sudden Infant Death Syndrome (SIDS) do not constitute a contraindication for the use of Quintanrix. 
Vročinski krči v anamnezi ali konvulzije oziroma sindrom nenadne smrti dojenčka (SIDS- Sudden Infant Death Syndrome) v družinski anamnezi ne predstavljajo kontraindikacije za uporabo cepiva Quintanrix.
More than 99% of subjects were considered to have responded to the pertussis component of the vaccine , which was defined as the appearance of antibodies in initially seronegative subjects (i.e. subjects with pre-vaccination titres < 15 ELU/ml) or a post-vaccination titre at least equal to pre-vaccination levels in subjects initially seropositive due to maternallyderived antibodies. 
Ocenjeno je bilo, da se je več kot 99 % oseb odzvalo na komponento cepiva proti oslovskemu kašlju, kar je definirano kot pojav protiteles pri osebah, ki so bile v izhodišču seronegativne (npr. osebe s titrom pred cepljenjem < 15 ELU/ml) ali osebah, ki so bile zaradi maternalnih protiteles v izhodišču seropozitivne, po cepljenju pa imajo vsaj enak titer kot pred cepljenjem.
Respiratory, thoracic and mediastinal disorders rare: bronchitis, coughing 
Bolezni dihal, prsnega koša in mediastinalnega prostora: redki: bronhitis, kašelj
Upon storage, a white deposit and clear supernatant may be observed for the DTPw-HBV component. 
Med shranjevanjem se lahko pri komponenti DTPw-HBV pojavi bela usedlina in bister supernatant.
Apnoea in very premature infants (≤ 28 weeks of gestation) (see section 4.4) 4.9 Overdose 
Apneja pri veliko prezgodaj rojenih nedonošenčkih (rojenih pred ali v 28. tednu nosečnosti) (glejte poglavje 4.4).
• if your child has a tendency to seizures/fits due to a fever, or if there is a history in the family of this 
• če je vaš otrok nagnjen k epileptičnim napadom/krčem zaradi zvišane telesne temperature ali pa se je to pojavljalo v družini;
Your doctor will be able to tell you what to do if Quintanrix is to be given with another vaccine or medicine. 
Zdravnik vam bo povedal kako ravnati v primeru, če bo vaš otrok prejel cepivo Quintanrix skupaj z drugim cepivom ali medtem, ko prejema druga zdravila.
In these circumstances the vaccination course should be continued with diphtheria, tetanus, hepatitis B and HIB vaccines. 
V takšnih primerih je potrebno cepljenje nadaljevati le s cepivi proti davici, tetanusu, hepatitisu B in HIB.
Make sure your child finishes the complete vaccination course of three injections. 
Preverite ali je vaš otrok v okviru osnovnega cepljenja prejel vse tri predpisane odmerke.
Total: 0.26 mg Al3+ 
Skupno: 0,26 mg Al 3+
≥ 60 IU 
≥ 60 i.e.
Forty-one percent had antibodies to pertussis. 
41 % otrok je imelo protitelesa proti oslovskemu kašlju.
QUALITATIVE AND QUANTITATIVE COMPOSITION After reconstitution, 1 dose (0.5 ml) contains: Diphtheria toxoid1 
KAKOVOSTNA IN KOLIČINSKA SESTAVA Po rekonstituciji cepiva 1 odmerek (0,5 ml) vsebuje: Davični toksoid1
Signs of an allergic reaction may include itchy skin rash, shortness of breath and swelling of the face or tongue. 
Znaki alergijske (preobčutljivostne) reakcije lahko vključujejo srbeč kožni izpuščaj, zasoplost in zatekanje obraza ali jezika;
The expected immunological response may not be obtained after vaccination of immunosuppressed patients. 
Možno je, da pri bolnikih z imunosupresivnim zdravljenjem po cepljenju ni dosežen pričakovani imunski odziv.
3, 4, 5 months schedule N = 107 
Shema 3., 4., 5. mesec N = 107
- Keep this leaflet until your child has finished the complete vaccination course. 
- Navodilo shranite, dokler cepljenje vašega otroka ni zaključeno.
Although no data are available on the immune response to the Bacille-CalmetteGuérin (BCG) antigen, no interference is expected. 
Glede imunskega odziva na antigen BCG (Bacille-Calmette-Guérin) sicer ni podatkov, vendar pa se oviranje imunskega odziva na cepivo MMR ne pričakuje.
Marketing authorisation holder and Manufacturer: GlaxoSmithKline Biologicals s.a. Rue de l'Institut 89 
Imetnik dovoljenja za promet in izdelovalec: GlaxoSmithKline Biologicals s.a. Rue de l'Institut 89
The HIB component of the vaccine does not protect against diseases due to capsular serotypes other than type b of Haemophilus influenzae or against meningitis caused by other organisms. 
HIB komponenta cepiva ščiti le pred boleznimi zaradi tipa b, ne pa pred boleznimi zaradi drugih kapsularnih serotipov Haemophilusa influenzae, prav tako ne ščiti pred meningitisom zaradi drugih povzročiteljev.
• if your child has previously had an allergic reaction to any vaccine against diphtheria, tetanus, pertussis (whooping cough), hepatitis B or Haemophilus influenzae type b diseases. 
• če je imel vaš otrok kdaj alergijsko (preobčutljivostno) reakcijo na katero koli cepivo proti davici, tetanusu, oslovskemu kašlju, hepatitisu B ali boleznim, ki jih povzroča Haemophilus influenzae tipa b;
Psychiatric disorders: very common: irritability 
Psihiatrične motnje: zelo pogosti: razdražljivost
Quintanrix should not be given to subjects with hypersensitivity to the active substances or to any of the excipients. 
S cepivom Quintanrix ne smejo biti cepljene osebe, ki so preobčutljive za aktivne sestavine ali katero koli pomožno snov cepiva Quintanrix.
Total: 0.26 milligrams Al3+ 
Skupno: 0,26 miligrama Al 3+
In the following cases, Quintanrix should not be given to your child. You must tell your doctor: 
V naslednjih primerih se cepivo Quintanrix vašemu otroku ne sme dati.
2 doses (1 ml) 
2 odmerka (1 ml)